Scientific Opinion on the safety of advantame for the proposed uses as a food additive

EFSA Journal

Volumn 11, Issue 7, 2013, Pages

[No Author Info available]

Author keywords

advantame; ANS980; ANS9801 acid; CAS Registry Number 714229 20 6; food additive; intense sweetener

Indexed keywords

EID: 85062303450     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2013.3301     Document Type: Article

References (29)

1. AFSSA (Agence française de sécurité sanitaire des aliments), 2007. Apport en protéines: consommation, qualité, besoins et recommandations. Maisons-Alfort, request number 2004-SA-0052.
2. COT (Committee on Toxicity), 2011. Committee on Toxicity of Chemicals in Food, Consumer Products and the Enviroment. COT statement on the effects of chronic dietary exposure to methanol.
3. Chowaniec J and Hicks RM, 1979. Response of the rat to saccharin with particular reference to the urinary bladder. British Journal of Cancer, 39, 355–375.
4. EFSA (European Food Safety Authority), 2007. Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food. Neotame as a sweetener and flavour enhancer. The EFSA Journal, 581, 1–43.
5. EFSA (European Food Safety Authority), 2011a. Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment. EFSA Journal 2011;9(3):2097, 34 pp. doi:10.2903/j.efsa.2011.2097
6. EFSA (European Food Safety Authority), 2011b. Evaluation of the FoodEx, the food classification system applied to the development of the EFSA Comprehensive European Food Consumption Database. EFSA Journal 2011;9(3):1970, 27 pp. doi:10.2903/j.efsa.2011.1970
7. EFSA Scientific Committee, 2012. Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. EFSA Journal 2012;10(3):2579, 32 pp. doi:10.2903/j.efsa.2012.2579.
8. Egermann J, Koenig J. Abschaetzung der Aufnahme von Aspartat, Phenylalanin und Methanol aus dem Suessstoff Aspartam im Vergleich zu natuerlichen Quellen bei europaeischen Erwachsenen. Master Thesis at the Department of Nutritional Sciences, University of Vienna, Vienna, 2012.
9. Evans GO, 2009a. Animal haematoxicology. A practical guide for toxicologists and biomedical researches. CRP Press Taylor & Francis Group, LLC.
10. Evans, GO, 2009b. Animal clinical chemistry: a practical guide for toxicologists and biomedical researches. CRP Press Taylor & Francis Group, LLC.
11. FDA (Food and Drug Administration), 2002. Department of Health and Human Services. 21CFR Part 172. Food additives permitted for direct addition to food for human consumption; Neotame. Federal Register, 67 (131), 45300–45310.
12. Flamm WG, Blackburn GL, Comer CP, Mayhew DA, Stargel WW, 2003. Long-term food consumption and body weight changes in neotame safety studies are consistent with the allometric relationship observed for other sweeteners and during dietary restrictions. Regulatory Toxicology and Pharmacology, 38, 144–156.
13. st Assessment Report. 6 September 2010. Avaible online: www.foodstandards.gov.au/_srcfiles/A1034%20Advantame%201AR%20FINAL.pdf
14. nd Assessment Report. 14 February 2011.
15. Grice HC and Goldsmith LA, 2000. Sucralose – an overview of the toxicity data. Food and Chemical Toxicology, 38 (Suppl. 2), S1–S6.
16. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2013. Summary and Conclusions, Seventy-seventh meeting, Rome, 4–13 June 2013, issued 19 June 2013.
17. IOM (Institute of Medicine), 2005. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: The National Academies Press.
18. Mahew DA, Comer CP and Stargel WW, 2003. Food consumption and body weight changes with neotame, a new sweetener with intense taste: differentiating effects of palatability from toxicity in dietary safety studies. Regulatory Toxicology and Pharmacology, 38, 124–143.
19. Otabe A, Fujieda T and Masuyama T, 2011a. In vitro and in vivo assessment of the mutagenic activity of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-a-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame). Food and Chemical Toxicology, 49 (Suppl 1), S30–34.
20. Otabe A, Fujieda T and Masuyama T, 2011b. Chronic toxicity and carcinogenicity of N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]- -aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat. Food and Chemical Toxicology, 49 (Suppl 1), S35–48.
21. Otabe A, Fujieda T and Masuyama T, 2011c. Chronic oral toxicity of N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]- -aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the dog. Food and Chemical Toxicology, 49 (Suppl 1), S49–59.
22. Otabe A, Fujieda T and Masuyama T, 2011d. Evaluation of the teratogenic potential of N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]- -aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat and rabbit. Food and Chemical Toxicology, 49 (Suppl 1), S60–69.
23. Otabe A, Fujieda T and Masuyama T, 2011e. A two-generation reproductive toxicity study of the high-intensity sweetener advantame in CD rats. Food and Chemical Toxicology, 49 (Suppl 1), S70–76.
24. Rousseau AS, Ducros V, Bouchard X and Margaritis I, 2006. Sports d'endurance: qualité des apports protéiques. Nutrition Clinique et Metabolisme, 20, S149.
25. Tricker AR and Preussmann R, 1988. N-nitroso compounds and their precursors in the human environment. In: Hill, M.J., ed. Nitrosamines: Toxicology and Microbiology. VCH Publishers, Inc., Weinheim, Germany / New York. Ellis Horwood Series in Food Science and Technology, pp. 88–116.
26. Tricker AR and Kubacki SJ. 1992. Review of the occurrence and formation of non-volatile N-nitroso compounds in foods. Food Additives and Contaminants, 9, 39–69.
27. Ubakata K, Nakayama A and Mihara RD, 2011. Pharmacokinetics and metabolism of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-a-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat, dog, and man. Food and Chemical Toxicology, 49 (Suppl 1), S8–29.
28. Warrington S, Lee C, Otabe A, Narita T, Polnjak O, Pirags V, and Krievins D 2011. Acute and multiple-dose studies to determine the safety, tolerability, and pharmacokinetic profile of advantame in healthy volunteers. Food and Chemical Toxicology, 49 (Suppl 1), S77–83.
29. WHO (World Health Organisation), 2007. Protein and Amino Acid Requirements in Human Nutrition. WHO Technical Report Series 935, 1–265.